Longitudinal Changes in Prorenin and Renin in the Chronic Renal Insufficiency Cohort.


Journal

American journal of nephrology
ISSN: 1421-9670
Titre abrégé: Am J Nephrol
Pays: Switzerland
ID NLM: 8109361

Informations de publication

Date de publication:
2021
Historique:
received: 28 10 2020
accepted: 08 01 2021
pubmed: 19 3 2021
medline: 17 11 2021
entrez: 18 3 2021
Statut: ppublish

Résumé

Prorenin, a precursor of renin, and renin play an important role in regulation of the renin-angiotensin system. More recently, receptor-bound prorenin has been shown to activate intracellular signaling pathways that mediate fibrosis, independent of angiotensin II. Prorenin and renin may thus be of physiologic significance in CKD, but their plasma concentrations have not been well characterized in CKD. We evaluated distribution and longitudinal changes of prorenin and renin concentrations in the plasma samples collected at follow-up years 1, 2, 3, and 5 of the Chronic Renal Insufficiency Cohort (CRIC) study, an ongoing longitudinal observational study of 3,939 adults with CKD. Descriptive statistics and multivariable regression of log-transformed values were used to describe cross-sectional and longitudinal variation and associations with participant characteristics. A total of 3,361 CRIC participants had plasma available for analysis at year 1. The mean age (±standard deviation, SD) was 59 ± 11 years, and the mean estimated glomerular filtration rate (eGFR, ± SD) was 43 ± 17 mL/min per 1.73 m2. Median (interquartile range) values of plasma prorenin and renin at study entry were 4.4 (2.1, 8.8) ng/mL and 2.0 (0.8, 5.9) ng/dL, respectively. Prorenin and renin were positively correlated (Spearman correlation 0.51, p < 0.001) with each other. Women and non-Hispanic blacks had lower prorenin and renin values at year 1. Diabetes, lower eGFR, and use of angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, statins, and diuretics were associated with higher levels. Prorenin and renin decreased by a mean of 2 and 5% per year, respectively. Non-Hispanic black race and eGFR <30 mL/min/1.73 m2 at year 1 predicted a steeper decrease in prorenin and renin over time. In addition, each increase in urinary sodium excretion by 2 SDs at year 1 increased prorenin and renin levels by 4 and 5% per year, respectively. The cross-sectional clinical factors associated with prorenin and renin values were similar. Overall, both plasma prorenin and renin concentrations decreased over the years, particularly in those with severe CKD at study entry.

Identifiants

pubmed: 33735863
pii: 000514302
doi: 10.1159/000514302
pmc: PMC8049970
mid: NIHMS1668087
doi:

Substances chimiques

Angiotensin Receptor Antagonists 0
Angiotensin-Converting Enzyme Inhibitors 0
Hydroxymethylglutaryl-CoA Reductase Inhibitors 0
Sodium 9NEZ333N27
Renin EC 3.4.23.15

Types de publication

Journal Article Observational Study Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

141-151

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR002548
Pays : United States
Organisme : NCRR NIH HHS
ID : UL1 RR024131
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK061022
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK119199
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000003
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000439
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK099098
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK060990
Pays : United States
Organisme : NCRR NIH HHS
ID : UL1 RR029879
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK061028
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000433
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK060984
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK061021
Pays : United States
Organisme : NIDDK NIH HHS
ID : U24 DK060990
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK060980
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002538
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK060963
Pays : United States
Organisme : NCRR NIH HHS
ID : M01 RR016500
Pays : United States
Organisme : NIGMS NIH HHS
ID : P20 GM109036
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK060902
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000424
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK123727
Pays : United States

Informations de copyright

© 2021 S. Karger AG, Basel.

Références

Am J Physiol Renal Physiol. 2016 Dec 1;311(6):F1145-F1148
pubmed: 27681562
J Am Soc Nephrol. 2003 Jul;14(7 Suppl 2):S148-53
pubmed: 12819321
Am J Physiol Heart Circ Physiol. 2008 Sep;295(3):H1117-H1121
pubmed: 18621861
Curr Hypertens Rep. 2016 Apr;18(4):29
pubmed: 26951246
J Am Soc Nephrol. 2007 Jun;18(6):1789-95
pubmed: 17494887
Arch Intern Med. 1988 Apr;148(4):937-41
pubmed: 3281621
Hypertension. 2017 Apr;69(4):564-574
pubmed: 28242715
J Am Soc Nephrol. 2017 Aug;28(8):2393-2408
pubmed: 28270411
Hypertension. 2014 Jul;64(1):103-10
pubmed: 24752431
J Hypertens. 1991 Mar;9(3):265-74
pubmed: 1851790
Curr Hypertens Rep. 2008 Apr;10(2):112-8
pubmed: 18474177
J Clin Invest. 1996 Nov 1;98(9):1966-70
pubmed: 8903314
Br J Ophthalmol. 2005 Jul;89(7):871-3
pubmed: 15965169
J Clin Invest. 2002 Jun;109(11):1417-27
pubmed: 12045255
J Clin Endocrinol Metab. 1989 Jan;68(1):160-7
pubmed: 2642484
Hypertension. 1991 Apr;17(4):469-77
pubmed: 2013474
Exp Cell Res. 2012 May 15;318(9):1049-56
pubmed: 22410251
Clin J Am Soc Nephrol. 2009 Aug;4(8):1302-11
pubmed: 19541818
J Biol Chem. 1995 Jul 7;270(27):16355-9
pubmed: 7608205
J Renin Angiotensin Aldosterone Syst. 2011 Sep;12(3):290-4
pubmed: 21330419
Front Biosci. 2008 May 01;13:3931-9
pubmed: 18508487
Am J Hypertens. 2012 Aug;25(8):839-47
pubmed: 22237158
Hypertension. 1992 May;19(5):456-63
pubmed: 1568764
J Hypertens. 2011 Nov;29(11):2226-35
pubmed: 21941205
J Diabetes Complications. 1999 Jan-Feb;13(1):45-51
pubmed: 10232709
J Clin Invest. 2004 Oct;114(8):1128-35
pubmed: 15489960
Cochrane Database Syst Rev. 2017 Apr 09;4:CD004022
pubmed: 28391629
J Hypertens. 2005 Feb;23(2):459-60; author reply 460
pubmed: 15662236
Hypertension. 2008 Jun;51(6):1597-604
pubmed: 18413493
Kidney Int. 2019 May;95(5):1041-1052
pubmed: 30819554
J Clin Endocrinol Metab. 1990 Oct;71(4):1008-15
pubmed: 2205621
J Am Soc Nephrol. 2006 Dec;17(12):3293-9
pubmed: 17093063

Auteurs

Monique E Cho (ME)

Division of Nephrology and Hypertension, University of Utah, Salt Lake City, Utah, USA, Monique.Cho@hsc.utah.edu.

Carol Sweeney (C)

Division of Epidemiology, University of Utah, Salt Lake City, Utah, USA.

Nora Fino (N)

Division of Epidemiology, University of Utah, Salt Lake City, Utah, USA.

Tom Greene (T)

Division of Epidemiology, University of Utah, Salt Lake City, Utah, USA.

Nirupama Ramkumar (N)

Division of Nephrology and Hypertension, University of Utah, Salt Lake City, Utah, USA.

Yufeng Huang (Y)

Division of Nephrology and Hypertension, University of Utah, Salt Lake City, Utah, USA.

Ana C Ricardo (AC)

Department of Medicine, University of Illinois, Chicago, Illinois, USA.

Tariq Shafi (T)

Division of Nephrology, University of Mississippi, Jackson, Mississippi, USA.

Rajat Deo (R)

Division of Cardiovascular Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Amanda Anderson (A)

Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, Louisiana, USA.

Katherine T Mills (KT)

Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, Louisiana, USA.

Alfred K Cheung (AK)

Division of Nephrology and Hypertension, University of Utah, Salt Lake City, Utah, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH